The carboxyl terminus of the protein encoded by the c-MYC protooncogene has similarity to the helix-oophelix family of DNA-binding proteins and recognizes a sixnucleotide-long DNA sequence. We have used in vitro- 
Constitutive expression of the c-MYC oncogene leads to cellular transformation in vitro and the development of tumors in experimental animals (1, 2) . Furthermore human tumors are often associated with mutations that activate this gene (3) (4) (5) (6) .
Within the 90 carboxyl-terminal amino acids ofc-MYC, the protein product of the c-MYC oncogene, two motifs can be recognized; the helix-loop-helix (HLH) motif, which is preceded by a region rich in basic amino acids, and the leucine zipper motif, which immediately follows the HLH motif (7, 8) . Similar motifs are found in sequence-specific DNAbinding proteins, where they serve to mediate protein dimerization and subsequent DNA binding (7) (8) (9) (10) (11) .
The presence of these motifs in c-MYC suggests that c-MYC has sequence-specific DNA-binding activity. Indeed Blackwell et al. (12) expressed in Escherichia coli a fusion protein of glutathione S-transferase with the carboxyl terminus of c-MYC, and Prendergast and Ziff (13) in vitro translated an E12 HLH protein, which had 11 amino acids of the basic region substituted by the corresponding amino acids of c-MYC. Both the above fusion proteins recognize the DNA sequence CACGTG. To address whether the DNA-binding site of c-MYC extends beyond these six nucleotides, we incubated in vitro-translated c-MYC protein with a repertoire of DNA sequences and identified a 12-nucleotide-long sequence that is both necessary and sufficient for DNA binding by c-MYC. Furthermore, point mutations within the c-MYC DNA-binding domain abolish both DNA binding and transforming activities, indicating that c-MYC acts as a sequencespecific DNA-binding protein to transform cells.
MATERIALS AND METHODS
Recombinant Plasmids. Classical recombinant technology was used (14) . Plasmid pGEMmycB encodes a full-length human c-MYC protein (Fig. LA) . It is based on the pGEM4 vector (Promega). First the EcoRI-BamHI fragment of the polylinker was replaced by synthetic oligonucleotides that provide a protein translation initiation codon preceded by a consensus translation initiation sequence (15) . The c-MYC coding sequence was cloned as two separate fragments. The BamHI-Cla I fragment was derived from plasmid pOTS-myc (16) , whereas the Cla I-Xba I fragment was from M13mpllmycRsa. The latter is an M13mpll vector with a 980-base-pair (bp) genomic Rsa I fragment containing the third exon of c-MYC subcloned into the Sma I site of the polylinker. The BamHI site of the M13mpll polylinker was previously destroyed.
Plasmid pGEMmyc3X encodes the carboxyl-terminal 178 amino acids of c-MYC. It was derived from pGEMmycB by substituting the BamHI-Cla I c-MYC fragment with adaptor oligonucleotides (GATCCTGCTCGAGGAAT, upper strand; CGATTCCTCGAGCAG, lower strand).
Plasmid pGEMmycPp encodes the carboxyl-terminal 94 amino acids of c-MYC. This plasmid was derived from pGEMmycB by substituting the BamHI-PpuMI c-MYC fragment with adaptor oligonucleotides (GATCCTCTAGACAG, upper strand; GACCTGTCTAGAG, lower strand).
Site-directed mutagenesis was performed as described (17) using M13mpllmycRsa as the template. The mutant c-MYC fragments were subcloned into either pGEMmyc3X or pSV7hummyc as Cla I-Bcl I fragments.
Plasmid pGEMtfebPX encodes a fragment of the human transcription factor TFEB protein that contains the HLH motif and the adjacent leucine zipper. A Pst I-Xho I fragment of the TFEB gene was isolated from plasmid pUC1-4tfeb and cloned into pGEM4, which had the EcoRI-BamHII fragment of the polylinker replaced by the oligonucleotides that provide an initiation codon, as described above for pGEMmycB. Adaptor oligonucleotides were used to bridge the BamHI site of the vector to the Pst I site of the insert (15) . The Xho I site of the TFEB insert was ligated to the Sal I site of the pGEM4 vector.
DNA-Binding Assay. This assay was done as described (15) , except that poly(dIdC) was substituted with 100 ng per reaction of the following single-stranded oligonucleotide: CAGGAAGCAGGTCATGTGGCAAGGCTATT.
Rat Embryo Fibroblast Transformation Assay. This assay was done as described (18) , except that the cells were transfected as described by Chen and Okayama (19) .
RESULTS
In Vitro Translation of c-MYC. Several DNA-binding proteins, including members of the HLH family, bind DNA with specificity when expressed in an in vitro translation system (7, 9, 20) . The coding sequence of human c-MYC was therefore cloned into the pGEM4 vector (Promega) to generate in vitro-transcribed mRNA, which was then translated by using a rabbit reticulocyte lysate (Fig. LA) . Truncated versions were also generated. One of these, Myc3X, contained the amino acid sequences encoded by the third exon of c-MYC, whereas a further truncated protein, MycPp Fig. 2A) .
To determine whether the outer nucleotides GAC represent the optimum target site for c-MYC we substituted each of these nucleotides one at a time with every other possible nucleotide. Two such variants, GAG and GAT, had already been tested ( Fig. 2A) . Of all additional variants tested only GCC failed to bind to MycPp ( Fig. 2B ; note that a rabbit reticulocyte lysate protein formed a complex with the GCC variant DNA, but this complex could be observed even when the reticulocyte lysate was not programmed by c-MYC RNA, data not shown). We conclude that c-MYC recognizes GAC as the outer nucleotides with high affinity but will bind equally well when a mismatch occurs at one of these positions, except for thymidine at the position closest to the central core CACGTG and cytosine at the middle position of the outer nucleotide triplet. Mismatch at two positions of the outer nucleotides is usually not tolerated because the oligonucleotide with CAA as the outer nucleotides did not bind to MycPp (Fig. 2A) . The inability of this sequence to be recognized over the sequence with GAA as the outer nucleotides (Fig. 21B) argues that the target site of c-MYC is 12, rather than 10 nucleotides long.
To further demonstrate the importance of specific outer nucleotides for recognition by c-MYC, we examined the ability of the DNA with GAT as the outer nucleotides (nonspecific DNA) to compete for specific protein-DNA binding. Whereas 50-fold excess of nonlabeled specific DNA completely competed with binding of MycPp to the labeled DNA, the same excess of nonspecific DNA competed only slightly (Fig. 2C) .
All above examined DNAs contained CG as the inner nucleotides. To assess whether c-MYC had a specific sequence requirement for the inner nucleotides, we generated a variant of the high-affinity recognition site GACCACGTG-GTC, which has the inner nucleotides CG mutated to GC.
MycPp failed to bind to this DNA (Fig. 2D, lanes 1 and 2) . Furthermore 200-fold excess of this variant DNA competed only slightly with MycPp-specific DNA binding, whereas the same excess of specific DNA competed completely (Fig. 2D ,
The general HLH protein consensus recognition sequence can be considered to be formed of two half-sites, each recognized by one subunit of a dimeric complex. We examined whether altering the spacing of the half-sites would eliminate c-MYC DNA binding. A variant of the high-affinity recognition site was generated that had the two inner nucleotides CG replaced by four: CGCG. MycPp failed to bind to this DNA (Fig. 2D, lanes 3 and 4) .
Recognition Sequence-Specific DNA Binding by Full-Length c-MYC. MycPp is a truncated version of c-MYC containing only the basic region, HLH, and leucine zipper elements. We examined whether bigger fragments of c-MYC protein would also bind DNA. Myc3X contains the amino acids encoded by the whole c-MYC third exon, whereas MycB is a full-length c-MYC protein (Figs. 1 A and B) . Both exhibited specific DNA-binding activity (Fig. 4, lanes 2 and 5) .
Point Mutations Within the HLH Motif of c-MYC Abolish
Both DNA Binding and Transforming Activity. To assess whether DNA binding is required for the transforming activity of c-MYC, we introduced point mutations within the protein that would abolish DNA binding. Mutant mjl has four amino acid substitutions within the first a-helix of the HLH motif, whereas mj2 has five substitutions within the upstream basic region (Fig. 4) . c-MYC proteins containing these mutations were efficiently translated in vitro (Fig. 1B ) but failed to bind DNA (Fig. 4) . The same mutations inactivated the transforming activity of c-MYC (Table 1) .
DISCUSSION
Determination of the DNA-Binding Site of c-MYC. The c-MYC protein has similarity to the HLH family of DNAbinding proteins. The consensus binding site of the latter, referred to as E-box, is CANNTG, suggesting that c-MYC might bind a related DNA sequence. Indeed Blackwell et al. (12) and Prendergast and Ziff (13) Fig. 2A ).
c-MYC as GACCACGTGGTC by using in vitro-translated protein.
c-MYC recognizes the same inner nucleotides, CG, as the HLH protein TFEB (21) . The similarity in DNA-recognition sequences reflects the high homology of the basic regions of these proteins. Nevertheless, c-MYC and transcription factor TFEB recognize different outer nucleotides, suggesting that they operate in distinct pathways in the cell.
In our search for DNA sequences recognized by c-MYC we have not used every possible combination of outer nucleotide sequences, and thus the question arises whether we have identified the optimum DNA target site. Substituting the outer nucleotides of the optimum site one at a time with every other possible nucleotide did not lead to appreciably increased binding affinity. Furthermore, c-MYC binds the target sequence we have identified as efficiently as transcription factor TFEB binds its optimum recognition site when equal concentrations of the two proteins are used (compare Figs. 2A and 3) .
Dimerization is a prerequisite for DNA binding by the HLH family of proteins; we therefore speculate that in vitro-translated c-MYC binds DNA as a dimer. This hypothesis is consistent with the inability ofthe protein to bind DNA when spacing of the half-sites is altered. c-MYC protein produced in E. coli forms dimers and tetramers (26) , whereas in vitro-translated c-MYC is a monomer (27) . The presence of specific DNA in our assay may drive dimerization of in vitro-translated c-MYC. (29, 30) . Determination of the c-MYC binding site as a 12-nucleotide-long sequence allowed us to identify putative gene targets because the frequency of random occurrence of a sequence of such length is low.
The c-SIS protooncogene encodes the B polypeptide of platelet-derived growth factor. Approximately 270 nucleotides upstream of the transcription initiation site, a 12-nucleotide element fits the c-MYC consensus binding site (31) . This element is conserved across species (32) and maps within an enhancer region (33) .
The mouse H19 gene encodes a protein of unknown function. The gene was identified by virtue of its coordinate regulation with the a-fetoprotein gene and its inducibility during liver regeneration (34) . One of the enhancers of this gene located at the 3' end contains a c-MYC DNA-binding site (35) .
The gene that encodes nucleolin, a major nucleolar protein involved in the synthesis and assembly of ribosomes, contains c-MYC DNA-binding sites within the first intron that are conserved across species (36, 37) . These regions have been speculated to be involved in gene transcription because they are bordered by G+C-rich sequences (36) .
The U3B RNA gene encodes a small nuclear RNA localized predominantly in the nucleolus that probably functions in pre-rRNA processing (38) . The gene is transcribed by RNA polymerase II and contains a c-MYC DNA-binding site within its 5' flanking sequences (39) . The 
